Morecare Pharmatec Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -26.90%
(FY 2023)
- Profit -495.35%
(FY 2023)
- Ebitda -246.45%
(FY 2023)
- Net Worth -218.93%
(FY 2023)
- Total Assets 6.03%
(FY 2023)
About Morecare Pharmatec
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Chauhan and Geeta Rani serve as directors at the Company.
- CIN/LLPIN
U24290HR2020PTC089103
- Company No.
089103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Morecare Pharmatec Private Limited offer?
Morecare Pharmatec Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Respiratory System Drugs, Anti Asthma Drug, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Morecare Pharmatec?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Chauhan  | Director | 03-Sep-2024 | Current |
| Geeta Rani | Director | 03-Sep-2024 | Current |
Financial Performance of Morecare Pharmatec.
Morecare Pharmatec Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.9% decrease. The company also saw a substantial fall in profitability, with a 495.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 218.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morecare Pharmatec?
Unlock access to Morecare Pharmatec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Morecare Pharmatec?
Morecare Pharmatec has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morecare Pharmatec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morecare Pharmatec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
